Mark W. Begor - 29 Jul 2022 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
29 Jul 2022
Net transactions value
$0
Form type
4
Filing time
02 Aug 2022, 17:30:05 UTC
Previous filing
01 Jul 2022
Next filing
03 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Award $0 +23,934 +30% $0.000000 103,798 29 Jul 2022 Direct F1, F2
holding EFX Common Stock 20,382 29 Jul 2022 2-Year 2021 GRAT
holding EFX Common Stock 40,000 29 Jul 2022 2-Year 2022 GRAT
holding EFX Common Stock 35,383 29 Jul 2022 4-Year 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Award $0 +48,281 $0.000000 48,281 29 Jul 2022 Common Stock 48,281 $250.69 Direct F3
transaction EFX Stock Option/Right to Buy Award $0 +43,440 $0.000000 43,440 29 Jul 2022 Common Stock 43,440 $229.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Special equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock vests 100% on 12/31/2025.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 Special equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 12/31/2025.